Mar 18, 2026 10:03AM
Mar 18, 2026 06:33AM
Mar 17, 2026 04:08PM
Mar 17, 2026 02:45PM
Mar 17, 2026 08:30AM
Mar 17, 2026 08:30AM
Dec 16, 2025 03:57AM Aldeyra Therapeutics receives FDA extension for dry eye drug review
Dec 15, 2025 07:30PM
Nov 13, 2025 07:00AM
Nov 13, 2025 07:00AM
Oct 28, 2025 07:01AM
Oct 28, 2025 07:01AM
Oct 8, 2025 12:58PM
Aug 28, 2025 07:02AM Aldeyra receives European orphan designation for eye cancer drug
Aug 28, 2025 07:01AM
Aug 19, 2025 07:01AM
Aug 19, 2025 07:01AM
Aug 8, 2025 12:20PM
Jul 24, 2025 07:01AM
Jul 24, 2025 07:00AM
Jul 17, 2025 07:02AM FDA accepts Aldeyra's reproxalap drug application for dry eye disease
Jul 17, 2025 07:00AM
Jun 26, 2025 08:18AM
Jun 26, 2025 07:00AM
Jun 26, 2025 07:00AM
Jun 18, 2025 03:02PM
Jun 17, 2025 07:02AM
Jun 17, 2025 07:00AM Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
May 18, 2025 10:00AM
May 13, 2025 01:22PM
May 9, 2025 08:00AM
May 6, 2025 07:08AM
May 5, 2025 06:34PM
May 5, 2025 02:12PM
May 4, 2025 08:18AM ALDX INQUIRY: BFA Law Notifies Aldeyra Therapeutics, Inc. Investors to Contact the Firm About Pending Investigation into the Company
May 2, 2025 03:33PM
May 1, 2025 03:18PM
Apr 30, 2025 07:36AM
Apr 29, 2025 11:16AM
Apr 28, 2025 07:11AM
Apr 26, 2025 07:08AM
Apr 25, 2025 12:57PM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
Apr 24, 2025 07:36AM
Apr 22, 2025 07:17AM
Apr 21, 2025 02:30PM
Apr 20, 2025 07:37AM
Apr 18, 2025 03:23PM
Apr 17, 2025 03:11PM
Apr 17, 2025 12:47PM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
Apr 17, 2025 07:00AM

322,090 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All